Cancer treatment technology developed at Sussex to start preclinical tests

Written By Simon Mitchell

Professor John Spencer and Georgios Giamas

Building on research at Sussex, leading cancer researchers in the School of Life Sciences, Professor Georgios Giamas and Professor John Spencer launched Stingray Bio in 2021, to develop new therapies for breast cancers and potentially other cancer types. The new agreement with ValiRx is a big step in the path to commercialising new therapeutics for cancer patients.

Simon Mitchell
Previous

Dame Lesley presents at the UK Interdisciplinary Breast Cancer Symposium.
Next

Dr Ollie Minton, Rob Herriott and Tim Williams win Royal College of Physicians FIX IT prize